SG136110A1 - Tumor models employing green fluorescent protein - Google Patents

Tumor models employing green fluorescent protein

Info

Publication number
SG136110A1
SG136110A1 SG200702390-6A SG2007023906A SG136110A1 SG 136110 A1 SG136110 A1 SG 136110A1 SG 2007023906 A SG2007023906 A SG 2007023906A SG 136110 A1 SG136110 A1 SG 136110A1
Authority
SG
Singapore
Prior art keywords
fluorescent protein
green fluorescent
tumor models
models employing
employing green
Prior art date
Application number
SG200702390-6A
Other languages
English (en)
Inventor
Weiguo Qing
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG136110A1 publication Critical patent/SG136110A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG200702390-6A 2006-03-31 2007-03-30 Tumor models employing green fluorescent protein SG136110A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78825006P 2006-03-31 2006-03-31

Publications (1)

Publication Number Publication Date
SG136110A1 true SG136110A1 (en) 2007-10-29

Family

ID=37944052

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200702390-6A SG136110A1 (en) 2006-03-31 2007-03-30 Tumor models employing green fluorescent protein

Country Status (6)

Country Link
US (1) US7749486B2 (fr)
EP (2) EP2037270A3 (fr)
JP (1) JP2007275060A (fr)
CN (1) CN101046471A (fr)
CA (1) CA2582236A1 (fr)
SG (1) SG136110A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120260355A1 (en) * 2009-12-22 2012-10-11 The Trustees Of Columbia University In The City Of New York Method for Evaluating Inhibitory Polynucleotide Efficiency and Efficacy
RU2475864C1 (ru) * 2011-06-20 2013-02-20 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Минздравсоцразвития России" Способ получения опухолей легкого в эксперименте
CN112635067A (zh) * 2020-12-29 2021-04-09 上海市第十人民医院 基于深度学习的核素骨显像中骨转移瘤的诊断方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251384B1 (en) * 1997-04-28 2001-06-26 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
WO1998049336A1 (fr) * 1997-04-28 1998-11-05 Anticancer, Inc. Metastases modeles utilisant une proteine fluorescente verte (gfp) comme marqueur
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
AU765703B2 (en) * 1998-03-27 2003-09-25 Bruce J. Bryan Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
FR2796393B1 (fr) * 1999-07-15 2003-10-31 Inst Nat Sante Rech Med Modele d'etude de la progression de metastases pulmonaires spontanees, et son utilisation dans le criblage de medicaments
CA2575591A1 (fr) * 2003-08-08 2005-02-17 Yuji Shino Composition pharmaceutique pour le traitement de cancers
JP4434882B2 (ja) * 2004-08-27 2010-03-17 オリンパス株式会社 レーザ走査型蛍光観察装置

Also Published As

Publication number Publication date
EP1840570A1 (fr) 2007-10-03
JP2007275060A (ja) 2007-10-25
CN101046471A (zh) 2007-10-03
US7749486B2 (en) 2010-07-06
EP2037270A3 (fr) 2009-03-25
US20070231789A1 (en) 2007-10-04
CA2582236A1 (fr) 2007-09-30
EP2037270A2 (fr) 2009-03-18

Similar Documents

Publication Publication Date Title
EP1996700A4 (fr) Anticorps 141205-05 modifiant les maladies cancereuses
EP1838806A4 (fr) Nouveaux phosphores verts a base d'aluminate
EP2006377A4 (fr) Nouveaux peptides antigènes tumoraux
GB0611116D0 (en) Proteins
EP1996699A4 (fr) Anticorps 141205-04 modifiant les maladies cancéreuses
GB0601976D0 (en) Proteins
GB0514482D0 (en) Protein
GB0620735D0 (en) Proteins
GB0610140D0 (en) Protein stability
EP2044119A4 (fr) Anticorps modifiant les maladies cancereuses
EP1767635A4 (fr) Protéine fluorescente
SG136110A1 (en) Tumor models employing green fluorescent protein
EP2024516A4 (fr) Proteines de perforine-2
EP1994146A4 (fr) Anticorps 141205-02 modifiant les maladies cancéreuses
ZA200903282B (en) Cancerous disease modifying antibodies
GB0612443D0 (en) Protein
IL198316A0 (en) Cancerous disease modifying antibodies
EP2046381A4 (fr) Anticorps modifiant une maladie cancéreuse
GB0620304D0 (en) Protein
GB0614682D0 (en) Proteins
GB0612623D0 (en) Proteins
GB0411586D0 (en) Fluorescent protein
IL198359A0 (en) Cancerous disease modifying antibodies
GB0615655D0 (en) Protein
GB0616968D0 (en) Protein